Ability of mechanical reperfusion to salvage myocardium in patients with acute myocardial infarction presenting beyond 12 hours after onset of symptoms

American Heart Journal

Volumn 152, Issue 6, 2006, Pages 1133-1139

  Parodi, Guido ^a   Ndrepepa, Gjin ^c   Kastrati, Adnan ^c   Conti, Alberto ^a   Mehilli, Julinda ^c   Sciagrà, Roberto ^b   Schwaiger, Markus ^c   Antoniucci, David ^a   Schømig, Albert ^c  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART INFARCTION SIZE; HEART LEFT VENTRICLE; HEART MUSCLE; HEART MUSCLE REPERFUSION; HEART SCINTISCANNING; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COHORT STUDIES; CORONARY ANGIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTICENTER STUDIES; MYOCARDIAL INFARCTION; RADIONUCLIDE IMAGING; RANDOMIZED CONTROLLED TRIALS; STENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 33845189327     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2006.08.007     Document Type: Article

References (32)

1. Zahn R., Schiele R., Schneider S., et al. Primary angioplasty versus no reperfusion therapy in patients with acute myocardial infarction and a pre-hospital delay of >12-24 hours: results from the pooled data of the maximal individual therapy in acute myocardial infarction (MITRA) registry and the myocardial infarction registry (MIR). J Invasive Cardiol 13 (2001) 367-372
2. Elad Y., French W.J., Shavelle D.M., et al. Primary angioplasty and selection bias in patients presenting late (>12 h) after onset of chest pain and ST elevation myocardial infarction. J Am Coll Cardiol 39 (2002) 826-833
3. Kimura A., Ishikawa K., and Ogawa I. Myocardial salvage by reperfusion 12 hours after coronary ligation in dogs. Jpn Circ J 62 (1998) 294-298
4. Sabia P.J., Powers E.R., Ragosta M., et al. An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction. N Engl J Med 327 (1992) 1825-1831
5. Schulz R., Rose J., Martin C., et al. Development of short-term myocardial hibernation. Its limitation by the severity of ischemia and inotropic stimulation. Circulation 88 (1993) 684-695
6. Milavetz J.J., Giebel D.W., Christian T.F., et al. Time to therapy and salvage in myocardial infarction. J Am Coll Cardiol 31 (1998) 1246-1251
7. Schömig A., Mehilli J., Antoniucci D., et al. Mechanical reperfusion in patients with acute myocardial infarction presenting more than 12 hours from symptom onset: a randomized controlled trial. JAMA 293 (2005) 2865-2872
8. Kastrati A., Mehilli J., Schlotterbeck K., et al. Early administration of reteplase plus abciximab vs abciximab alone in patients with acute myocardial infarction referred for percutaneous coronary intervention: a randomized controlled trial. JAMA 291 (2004) 947-954
9. TIMI Study Group. The thrombolysis in myocardial infarction (TIMI) trial. N Engl J Med 312 (1985) 932-936
10. Rentrop K.P., Cohen M., Blanke H., et al. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 5 (1985) 587-592
11. Antman E.M., Anbe D.T., Armstrong P.W., et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 110 (2004) e82-e292
12. Van de Werf F., Ardissino D., Betriu A., et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 24 (2003) 28-66
13. Yusuf S., Lopez R., Maddison A., et al. Variability of electrocardiographic and enzyme evolution of myocardial infarction in man. Br Heart J 45 (1981) 271-280
14. Kloner R.A., Shook T., Antman E.M., et al. Prospective temporal analysis of the onset of preinfarction angina versus outcome: an ancillary study in TIMI-9B. Circulation 97 (1998) 1042-1045
15. Rentrop K.P., Feit F., Sherman W., et al. Late thrombolytic therapy preserves left ventricular function in patients with collateralized total coronary occlusion: primary end point findings of the Second Mount Sinai-New York University Reperfusion Trial. J Am Coll Cardiol 14 (1989) 58-64
16. Antoniucci D., Valenti R., Moschi G., et al. Relation between preintervention angiographic evidence of coronary collateral circulation and clinical and angiographic outcomes after primary angioplasty or stenting for acute myocardial infarction. Am J Cardiol 89 (2002) 121-125
17. Sawyer D.B., and Loscalzo J. Myocardial hibernation: restorative or preterminal sleep?. Circulation 105 (2002) 1517-1519
18. Heusch G., Schulz R., and Rahimtoola S.H. Myocardial Hibernation-a delicate balance. Am J Physiol Heart Circ Physiol 288 (2005) H984-H999
19. White H.D. Should all occluded infarct-related arteries be opened?. Eur Heart J 18 (1997) 1207-1209
20. Abbate A., Bussani R., Biondi-Zoccai G.G., et al. Persistent infarct-related artery occlusion is associated with an increased myocardial apoptosis at postmortem examination in humans late after an acute myocardial infarction. Circulation 106 (2002) 1051-1054
21. Fliss H., and Gattinger D. Apoptosis in ischemic and reperfused rat myocardium. Circ Res 79 (1996) 949-956
22. Lee K.S., Marwick T.H., Cook S.A., et al. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization. Circulation 90 (1994) 2687-2694
23. Gioia G., Powers J., Heo J., et al. Prognostic value of rest-redistribution tomographic thallium-201 imaging in ischemic cardiomyopathy. Am J Cardiol 75 (1995) 759-762
24. Kastrati A., Mehilli J., Nekolla S., et al. A randomized trial comparing myocardial salvage achieved by coronary stenting versus balloon angioplasty in patients with acute myocardial infarction considered ineligible for reperfusion therapy. J Am Coll Cardiol 43 (2004) 734-741
25. Antoniucci D., Rodriguez A., Hempel A., et al. A randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarction. J Am Coll Cardiol 42 (2003) 1879-1885
26. Sciagrà R., Parodi G., Pupi A., et al. Gated SPECT evaluation of outcome after abciximab-supported primary infarct artery stenting for acute myocardial infarction: the scintigraphic data of the abciximab and carbostent evaluation (ACE) randomized trial. J Nucl Med 46 (2005) 722-727
27. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 2 (1988) 349-360
28. ISIS-1 (First International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1. Lancet 2 (1986) 57-66
29. Hammerman H., Kloner R.A., Briggs L.L., et al. Enhancement of salvage of reperfused myocardium by early beta-adrenergic blockade (timolol). J Am Coll Cardiol 3 (1984) 1438-1443
30. Collins R., Peto R., Baigent C., et al. Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction. N Engl J Med 336 (1997) 847-860
31. Sabatine M.S., Cannon C.P., Gibson C.M., et al. CLARITY-TIMI 28 Investigators. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med 352 (2005) 1179-1189
32. Schömig A., Kastrati A., Dirschinger J., et al. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators. N Engl J Med 343 (2000) 385-391